Electromedical Technologies Financials
| EMED Stock | USD 0.0003 0.0001 25.00% |
Electromedical |
Understanding current and past Electromedical Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Electromedical Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Electromedical Technologies' assets may result in an increase in income on the income statement.
Please note, the presentation of Electromedical Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Electromedical Technologies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Electromedical Technologies' management manipulating its earnings.
Electromedical Technologies Stock Summary
Electromedical Technologies competes with Cellink AB, Bone Biologics, BICO Group, Aurora Spine, and Tenon Medical. Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company was founded in 2002 and is headquartered in Scottsdale, Arizona. Electromedical Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 16561 North 92nd |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.electromedtech.com |
| Phone | 480 292 8976 |
| Currency | USD - US Dollar |
Electromedical Technologies Key Financial Ratios
There are many critical financial ratios that Electromedical Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Electromedical Technologies reports annually and quarterly.| Return On Asset | -1.36 | |||
| Beta | 1.44 |
Electromedical Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Electromedical Technologies's current stock value. Our valuation model uses many indicators to compare Electromedical Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Electromedical Technologies competition to find correlations between indicators driving Electromedical Technologies's intrinsic value. More Info.Electromedical Technologies is rated # 3 in return on asset category among its peers. It is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Electromedical Technologies' earnings, one of the primary drivers of an investment's value.Electromedical Technologies Systematic Risk
Electromedical Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Electromedical Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Electromedical Technologies correlated with the market. If Beta is less than 0 Electromedical Technologies generally moves in the opposite direction as compared to the market. If Electromedical Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Electromedical Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Electromedical Technologies is generally in the same direction as the market. If Beta > 1 Electromedical Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Electromedical Technologies December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Electromedical Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Electromedical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Electromedical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Electromedical Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Electromedical Technologies's daily price indicators and compare them against related drivers.
| Downside Deviation | 25.85 | |||
| Information Ratio | 0.0307 | |||
| Maximum Drawdown | 73.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 |
Complementary Tools for Electromedical Pink Sheet analysis
When running Electromedical Technologies' price analysis, check to measure Electromedical Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromedical Technologies is operating at the current time. Most of Electromedical Technologies' value examination focuses on studying past and present price action to predict the probability of Electromedical Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromedical Technologies' price. Additionally, you may evaluate how the addition of Electromedical Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |